Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Holdco Nuvo Group D.G Ltd. (NUVOQ : OTC)
 
 • Company Description   
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring principally in Israel, the United States and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic. Holdco Nuvo Group D.G Ltd is based in Tel Aviv, Israel.

Number of Employees: 59

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.00 Daily Weekly Monthly
20 Day Moving Average: 18,040 shares
Shares Outstanding: 33.26 (millions)
Market Capitalization: $0.03 (millions)
Beta: 1.28
52 Week High: $1.23
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 12.50% 7.42%
12 Week 0.00% -15.61%
Year To Date -70.00% -71.81%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
94 YIGAL ALON ST.
-
TEL AVIV,L3 6789139
ISR
ph: 1-800-554-9041
fax: -
None http://www.nuvocares.com
 
 • General Corporate Information   
Officers
Robert Powell - Chief Executive Officer; Director
Gerald Ostrov - Chairman and Director
Douglas Blankenship - Chief Financial Officer
Laurence Klein - Director
Christina Spade - Director

Peer Information
Holdco Nuvo Group D.G Ltd. (ABMD)
Holdco Nuvo Group D.G Ltd. (DMDS)
Holdco Nuvo Group D.G Ltd. (CPWY.)
Holdco Nuvo Group D.G Ltd. (EQUR)
Holdco Nuvo Group D.G Ltd. (ECIA)
Holdco Nuvo Group D.G Ltd. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: M53051104
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 33.26
Most Recent Split Date: (:1)
Beta: 1.28
Market Capitalization: $0.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©